Back to search results

Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Prosthetic-joint Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Clinical Trial Site, Sarasota, Florida, United States

  • Clinical Trial Site, Tamarac, Florida, United States

  • Clinical Trial Site, Baltimore, Maryland, United States

  • Clinical Trial Site, Boston, Massachusetts, United States

  • Clinical Trial Site, New York, New York, United States

  • Clinical Trial Site, Leland, North Carolina, United States

  • Clinical Trial Site, Cincinnati, Ohio, United States

  • Clinical Trial Site, Cleveland, Ohio, United States

  • Clinical Trial Site, Columbus, Ohio, United States

  • Clinical Trial Site, Pittsburgh, Pennsylvania, United States

  • Clinical Trial Site, Dallas, Texas, United States

  • Clinical Trial Site, Edinburg, Texas, United States

  • Clinical Trial Site, Morgantown, West Virginia, United States

View source on ClinicalTrials.gov(opens in a new tab)